(Q39183960)

9 September 2017

title

Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality (English)

1 reference

9 September 2017

0 references

1 reference

Nabarun Dasgupta

1

0 references

Michele Jonsson Funk

series ordinal

2

object named as

Michele Jonsson Funk

1 reference

9 September 2017

Scott K. Proescholdbell

series ordinal

3

object named as

Scott Proescholdbell

1 reference

9 September 2017

5

Kurt M Ribisl

1 reference

9 September 2017

Annie Hirsch

4

1 reference

9 September 2017

Steve Marshall

series ordinal

6

1 reference

9 September 2017

publication date

1 September 2015

1 reference

9 September 2017

1 reference

9 September 2017

volume

17

1 reference

9 September 2017

issue

1

1 reference

9 September 2017

page(s)

85-98

1 reference

Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment

9 September 2017

cites work

1 reference

Rethinking opioid prescribing to protect patient safety and public health

21 January 2018

1 reference

Opioid analgesics--risky drugs, not risky patients

21 January 2018

1 reference

Pharmaceutical overdose deaths, United States, 2010.

21 January 2018

1 reference

High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009.

21 January 2018

1 reference

A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels

21 January 2018

1 reference

Trends in medical use and abuse of opioid analgesics

21 January 2018

1 reference

Association between non-medical and prescriptive usage of opioids

21 January 2018

1 reference

Increasing deaths from opioid analgesics in the United States

21 January 2018

1 reference

Opioid analgesics and rates of fatal drug poisoning in the United States

21 January 2018

1 reference

Relationship of opioid prescription sales and overdoses, North Carolina.

21 January 2018

1 reference

Studying adverse events related to prescription opioids: the Utah experience.

21 January 2018

1 reference

Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008-2009.

21 January 2018

1 reference

Surveillance of methadone-related adverse drug events using multiple public health data sources.

21 January 2018

1 reference

A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it.

21 January 2018

1 reference

Opioid prescriptions for chronic pain and overdose: a cohort study

21 January 2018

1 reference

Opioid dose and drug-related mortality in patients with nonmalignant pain

21 January 2018

1 reference

A history of being prescribed controlled substances and risk of drug overdose death.

21 January 2018

1 reference

Association between opioid prescribing patterns and opioid overdose-related deaths

21 January 2018

1 reference

Assessing risk for drug overdose in a national cohort: role for both daily and total opioid dose?

21 January 2018

1 reference

Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review

21 January 2018

1 reference

High-risk use by patients prescribed opioids for pain and its role in overdose deaths

21 January 2018

1 reference

Opioid poisonings in Washington State Medicaid: trends, dosing, and guidelines

21 January 2018

1 reference

Polydrug abuse: a review of opioid and benzodiazepine combination use

21 January 2018

1 reference

National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009.

21 January 2018

1 reference

Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: considerations for palliative care practice

21 January 2018

1 reference

Method to determine allocation of clinical pharmacist resources

21 January 2018

1 reference

Beyond the intention-to-treat in comparative effectiveness research

21 January 2018

1 reference

Benzodiazepine use in the United States

21 January 2018

1 reference

Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study

21 January 2018

1 reference

Race, care seeking, and utilization for chronic back and neck pain: population perspectives

21 January 2018

1 reference

Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States

21 January 2018

1 reference

Differential patterns of opioid use: defining persistent opioid use in a prescription database

21 January 2018

1 reference

HIV and risk environment for injecting drug users: the past, present, and future.

21 January 2018

1 reference

Project Lazarus: community-based overdose prevention in rural North Carolina

21 January 2018

1 reference

Obtaining adequate data to determine causes of opioid-related overdose deaths

21 January 2018

1 reference

Opioid-paracetamol prescription patterns and liver dysfunction: a retrospective cohort study in a population served by a US health benefits organization

21 January 2018

1 reference

An analysis of the root causes for opioid-related overdose deaths in the United States.

21 January 2018

1 reference

The ‘risk environment’: a framework for understanding and reducing drug-related harm

21 January 2018

1 reference

Risk environments and drug harms: A social science for harm reduction approach

21 January 2018

1 reference

Confidence intervals for weighted sums of poisson parameters

21 January 2018

1 reference

Opioids for the management of breakthrough (episodic) pain in cancer patients

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD004311.PUB2

Identifiers

DOI

10.1111/PME.12907

0 references

Fatcat ID

release_cie6wunu7fazxjsmy2emcsfxku

0 references

1 reference